|
summary: The authors report that patients treated with natalizumab, a newer therapy for severe MS, occasionally produce antibodies against the drug. It seems that these antibodies may sometimes alter its effectiveness.
authors: Calabresi PA, Giovannoni G, Confavreux C, Galetta SL, Havrdova E, Hutchinson M, Kappos L, Miller DH, O'connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Lublin FD, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; for the AFFIRM and SENTINEL Investigators.
source: Neurology. 2007 Aug 29; [Epub ahead of print]
weblink: click here
category: Immunology
related research news: click here
glossary:
Antibodies
Incidence
Sign
|
